Bicocca Open Archive

Logo unimib boa
AROLDI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.487
EU - Europa 1.378
AS - Asia 599
SA - Sud America 70
AF - Africa 12
OC - Oceania 1
Totale 3.547
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.472
IT - Italia 510
SG - Singapore 273
RU - Federazione Russa 260
DE - Germania 195
IE - Irlanda 133
CN - Cina 126
SE - Svezia 99
HK - Hong Kong 87
BR - Brasile 55
FR - Francia 32
GB - Regno Unito 31
ID - Indonesia 30
FI - Finlandia 29
IN - India 17
NL - Olanda 15
TR - Turchia 13
VN - Vietnam 13
ES - Italia 12
UA - Ucraina 11
CA - Canada 10
AT - Austria 9
PL - Polonia 9
AR - Argentina 8
CZ - Repubblica Ceca 8
EG - Egitto 8
PT - Portogallo 8
IR - Iran 6
PK - Pakistan 6
CO - Colombia 5
NO - Norvegia 5
BG - Bulgaria 3
IL - Israele 3
KG - Kirghizistan 3
KR - Corea 3
MX - Messico 3
AM - Armenia 2
AZ - Azerbaigian 2
CH - Svizzera 2
IQ - Iraq 2
JP - Giappone 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
MA - Marocco 2
PH - Filippine 2
RS - Serbia 2
AL - Albania 1
AU - Australia 1
BD - Bangladesh 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NP - Nepal 1
PA - Panama 1
TW - Taiwan 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 3.547
Salva come PNG Salva come JPEG
Città #
Ann Arbor 545
Singapore 178
Milan 173
Dublin 133
Frankfurt am Main 122
Chandler 86
Hong Kong 81
New York 75
Fairfield 70
Wilmington 68
Woodbridge 62
Santa Clara 53
Ashburn 45
Seattle 34
Houston 32
Shanghai 29
Jakarta 28
Los Angeles 24
Princeton 24
Cambridge 20
Lissone 19
Moscow 18
Rome 18
Hefei 17
Monza 17
Helsinki 14
Munich 14
Romola 14
Nuremberg 13
Guangzhou 12
Lawrence 12
Altamura 11
Bologna 10
Chicago 10
Desio 10
Beijing 9
Dallas 9
Sesto San Giovanni 9
Como 8
Dong Ket 8
Jacksonville 8
San Diego 8
Tianjin 8
Turin 8
Dearborn 7
Lappeenranta 7
London 7
Seregno 7
Boardman 6
Carate Brianza 6
Council Bluffs 6
Düsseldorf 6
Fremont 6
Garbsen 6
Lauterbourg 6
Turku 6
Andover 5
Olomouc 5
Sargodha 5
São Paulo 5
Assago 4
Bonndorf 4
Cinisello Balsamo 4
Falls Church 4
Genoa 4
Lisbon 4
Lodz 4
Oslo 4
Pavia 4
Pune 4
Sacramento 4
Tehran 4
Toronto 4
Agrate Brianza 3
Ankara 3
Arese 3
Bari 3
Bergamo 3
Berlin 3
Bishkek 3
Bogotá 3
Buenos Aires 3
Ceret 3
Chengdu 3
Colorado Springs 3
Corbetta 3
Delhi 3
Kocaeli 3
Legnano 3
Lleida 3
Nanchang 3
Portsmouth 3
Sacavém 3
Seriate 3
Tel Aviv 3
The Dalles 3
Usmate Velate 3
Vienna 3
Wroclaw 3
Aurora 2
Totale 2.394
Salva come PNG Salva come JPEG
Nome #
Chronic myeloid leukemia: Second-line drugs of choice 280
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 231
Evaluating the performance of large language models in haematopoietic stem cell transplantation decision-making 216
Integrated Genomic, Functional and Prognostic Characterization of Atypical Chronic Myeloid Leukemia (aCML) in a Cohort of 43 Patients 213
Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy 212
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis 199
Clinical Benefit of Lenzilumab in Cases of Coronavirus Disease 2019 180
Deferasirox in the management of iron-overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda (IRON-M study) 178
Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea 176
Treatment of Philadelphia-negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors 175
Idiopathic erythrocytosis: a germline disease? 148
Transfusion of blood products derived from SARS-CoV-2+ donors to patients with hematological malignancies 143
Neurological symptoms in essential thrombocythemia: Impact of JAK2V617F mutation and response to therapy 132
Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients 124
Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples 123
Tyrosine Kinase Inhibitor discontinuation in Chronic Myeloid Leukemia: eligibility criteria and predictors of success 122
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia 95
Iron chelation therapy with deferasirox in the management of iron overload in primary myelofibrosis 95
Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID-19 vaccine: A single-center prospective observational study (NCT05074706) 88
Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A single-center experience 82
A monocentric analysis of the long-term safety and efficacy of crizotinib in relapsed/refractory ALK+ lymphomas 82
Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype 62
Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies 53
Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia 50
Prognostic Biomarkers in Breast Cancer via Multi-Omics Clustering Analysis 48
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis 36
First-Hit SETBP1 Mutations Cause a Myeloproliferative Disorder with Bone Marrow Fibrosis Mimicking Triple Negative Myelofibrosis 32
ALK inhibitors increase ALK expression and sensitize neuroblastoma cells to ALK.CAR-T cells 23
Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Stem Cell Transplantation: Biology and Treatment Options 21
Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors 18
Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy 18
Real-world collection of secondary myeloid neoplasms after CD19 CAR-T cell therapy: first report of the ClonHema study 8
Totale 3.663
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.697
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.697
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010 0 0 0 0 0 0 0 0 0 0 5 5
2020/2021663 37 17 66 57 58 75 58 60 69 47 58 61
2021/2022295 52 36 48 38 14 23 4 8 7 10 17 38
2022/2023421 37 117 37 27 24 62 29 8 35 12 26 7
2023/2024650 14 20 30 27 61 175 96 25 67 42 26 67
2024/20251.454 56 141 88 76 119 88 113 69 170 323 211 0
Totale 3.663